Review



hy p0154  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    MedChemExpress hy p0154
    Hy P0154, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p0154/Epsilon-V1-2/pm39272131-93-21-22
    Average 93 stars, based on 5 article reviews
    hy p0154 - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: Buyang Huanwu Decoction restores the balance of mitochondrial dynamics after cerebral ischemia-reperfusion through calcium overload reduction by the PKCε-Nampt-Sirt5 axis.
    Article Snippet: Ethnopharmacological relevance: Stroke is a common condition that poses a significant threat to human health.. Buyang Huanwu Decoction (BYHWD) is a traditional treatment used for stroke management.. However, the exact mechanism by which BYHWD mitigates cerebral ischemia-reperfusion by regulating calcium overload and restoring mitochondrial function is not yet fully understood.

    Modification:

    Article Title: Buyang Huanwu Decoction restores the balance of mitochondrial dynamics after cerebral ischemia-reperfusion through calcium overload reduction by the PKCε-Nampt-Sirt5 axis.
    Article Snippet: Ethnopharmacological relevance: Stroke is a common condition that poses a significant threat to human health.. Buyang Huanwu Decoction (BYHWD) is a traditional treatment used for stroke management.. However, the exact mechanism by which BYHWD mitigates cerebral ischemia-reperfusion by regulating calcium overload and restoring mitochondrial function is not yet fully understood.

    Activation Assay:

    Article Title: Buyang Huanwu Decoction restores the balance of mitochondrial dynamics after cerebral ischemia-reperfusion through calcium overload reduction by the PKCε-Nampt-Sirt5 axis.
    Article Snippet: Ethnopharmacological relevance: Stroke is a common condition that poses a significant threat to human health.. Buyang Huanwu Decoction (BYHWD) is a traditional treatment used for stroke management.. However, the exact mechanism by which BYHWD mitigates cerebral ischemia-reperfusion by regulating calcium overload and restoring mitochondrial function is not yet fully understood.

    Expressing:

    Article Title: Buyang Huanwu Decoction restores the balance of mitochondrial dynamics after cerebral ischemia-reperfusion through calcium overload reduction by the PKCε-Nampt-Sirt5 axis.
    Article Snippet: Ethnopharmacological relevance: Stroke is a common condition that poses a significant threat to human health.. Buyang Huanwu Decoction (BYHWD) is a traditional treatment used for stroke management.. However, the exact mechanism by which BYHWD mitigates cerebral ischemia-reperfusion by regulating calcium overload and restoring mitochondrial function is not yet fully understood.

    Quantitative RT-PCR:

    Article Title: Buyang Huanwu Decoction restores the balance of mitochondrial dynamics after cerebral ischemia-reperfusion through calcium overload reduction by the PKCε-Nampt-Sirt5 axis.
    Article Snippet: Ethnopharmacological relevance: Stroke is a common condition that poses a significant threat to human health.. Buyang Huanwu Decoction (BYHWD) is a traditional treatment used for stroke management.. However, the exact mechanism by which BYHWD mitigates cerebral ischemia-reperfusion by regulating calcium overload and restoring mitochondrial function is not yet fully understood.

    Control:

    Article Title: Buyang Huanwu Decoction restores the balance of mitochondrial dynamics after cerebral ischemia-reperfusion through calcium overload reduction by the PKCε-Nampt-Sirt5 axis.
    Article Snippet: Ethnopharmacological relevance: Stroke is a common condition that poses a significant threat to human health.. Buyang Huanwu Decoction (BYHWD) is a traditional treatment used for stroke management.. However, the exact mechanism by which BYHWD mitigates cerebral ischemia-reperfusion by regulating calcium overload and restoring mitochondrial function is not yet fully understood.

    Western Blot:

    Article Title: Buyang Huanwu Decoction restores the balance of mitochondrial dynamics after cerebral ischemia-reperfusion through calcium overload reduction by the PKCε-Nampt-Sirt5 axis.
    Article Snippet: Ethnopharmacological relevance: Stroke is a common condition that poses a significant threat to human health.. Buyang Huanwu Decoction (BYHWD) is a traditional treatment used for stroke management.. However, the exact mechanism by which BYHWD mitigates cerebral ischemia-reperfusion by regulating calcium overload and restoring mitochondrial function is not yet fully understood.



    Similar Products

    93
    MedChemExpress hy p0154
    Hy P0154, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p0154/Epsilon-V1-2/pm39272131-93-21-22
    Average 93 stars, based on 1 article reviews
    hy p0154 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress pkcε inhibitor ε v1 2
    Pkcε Inhibitor ε V1 2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p0154/Epsilon-V1-2/pm40914752-53-31-38
    Average 93 stars, based on 1 article reviews
    pkcε inhibitor ε v1 2 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress εv1 2
    εv1 2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p0154/Epsilon-V1-2/pm39528118-103-6-13
    Average 93 stars, based on 1 article reviews
    εv1 2 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress epsilon v1
    Epsilon V1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p0154/Epsilon-V1-2/pm39272131-93-15-22
    Average 93 stars, based on 1 article reviews
    epsilon v1 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress epsilon-v1-2
    Epsilon V1 2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p0154/Epsilon-V1-2/custom%40hy-p0154%4036139727
    Average 93 stars, based on 1 article reviews
    epsilon-v1-2 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress pkcɛ inhibitor
    Fig. 6 SelS promotes hepatic insulin signaling via decreased <t>PKCɛ</t> activation in vitro. A, B The phosphorylation and total protein levels of IRS1 and Akt in SelS-KD and KD-CON (A), SelS-OE and OE-CON (B) <t>primary</t> <t>hepatocytes</t> treated with 0.5 mM PA or BSA for 24 h (n = 4 per group). Representative Western blotting images from 2 samples out of 4 for each group are shown. C, D Membrane/cytosol ratio of hepatic PKCɛ protein levels normalized with housekeeping proteins Na+/K+-ATPase and GAPDH in SelS-KD and KD-CON (C), SelS-OE and OE-CON (D) primary hepatocytes treated with 0.5 mM PA or BSA for 24 h (n = 4 per group). Representative images from two samples out of 4 for each group are shown. E–H After infection, the primary hepatocytes were preincubated with PKCɛ inhibitor (ε-V1-2, 1 μM) in SelS-KD and KD-CON groups (E, F) or PKCɛ activator (DCP-LA, 100 nM) in SelS-OE and OE-CON groups (G, H) for 1 h before stimulated with 0.5 mM PA or BSA for 24 h. The phosphorylation and total protein levels of IRS1 and Akt were examined by Western blotting in the indicated groups (n = 3 per group). Representative images from one sample out of 3 for each group are shown. All data are presented as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001. SelS-KD/KD-CON, SelS knockdown and the corresponding control; SelS-OE/OE-CON, SelS overexpression and the corresponding control; IRS1, insulin receptor substrate 1; Akt/PKB, protein kinase B; PKCɛ, protein kinase Cɛ.
    Pkcɛ Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p0154/Epsilon-V1-2/pm35347118-99-51-56
    Average 93 stars, based on 1 article reviews
    pkcɛ inhibitor - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 6 SelS promotes hepatic insulin signaling via decreased PKCɛ activation in vitro. A, B The phosphorylation and total protein levels of IRS1 and Akt in SelS-KD and KD-CON (A), SelS-OE and OE-CON (B) primary hepatocytes treated with 0.5 mM PA or BSA for 24 h (n = 4 per group). Representative Western blotting images from 2 samples out of 4 for each group are shown. C, D Membrane/cytosol ratio of hepatic PKCɛ protein levels normalized with housekeeping proteins Na+/K+-ATPase and GAPDH in SelS-KD and KD-CON (C), SelS-OE and OE-CON (D) primary hepatocytes treated with 0.5 mM PA or BSA for 24 h (n = 4 per group). Representative images from two samples out of 4 for each group are shown. E–H After infection, the primary hepatocytes were preincubated with PKCɛ inhibitor (ε-V1-2, 1 μM) in SelS-KD and KD-CON groups (E, F) or PKCɛ activator (DCP-LA, 100 nM) in SelS-OE and OE-CON groups (G, H) for 1 h before stimulated with 0.5 mM PA or BSA for 24 h. The phosphorylation and total protein levels of IRS1 and Akt were examined by Western blotting in the indicated groups (n = 3 per group). Representative images from one sample out of 3 for each group are shown. All data are presented as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001. SelS-KD/KD-CON, SelS knockdown and the corresponding control; SelS-OE/OE-CON, SelS overexpression and the corresponding control; IRS1, insulin receptor substrate 1; Akt/PKB, protein kinase B; PKCɛ, protein kinase Cɛ.

    Journal: Cell death & disease

    Article Title: Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance.

    doi: 10.1038/s41419-022-04716-w

    Figure Lengend Snippet: Fig. 6 SelS promotes hepatic insulin signaling via decreased PKCɛ activation in vitro. A, B The phosphorylation and total protein levels of IRS1 and Akt in SelS-KD and KD-CON (A), SelS-OE and OE-CON (B) primary hepatocytes treated with 0.5 mM PA or BSA for 24 h (n = 4 per group). Representative Western blotting images from 2 samples out of 4 for each group are shown. C, D Membrane/cytosol ratio of hepatic PKCɛ protein levels normalized with housekeeping proteins Na+/K+-ATPase and GAPDH in SelS-KD and KD-CON (C), SelS-OE and OE-CON (D) primary hepatocytes treated with 0.5 mM PA or BSA for 24 h (n = 4 per group). Representative images from two samples out of 4 for each group are shown. E–H After infection, the primary hepatocytes were preincubated with PKCɛ inhibitor (ε-V1-2, 1 μM) in SelS-KD and KD-CON groups (E, F) or PKCɛ activator (DCP-LA, 100 nM) in SelS-OE and OE-CON groups (G, H) for 1 h before stimulated with 0.5 mM PA or BSA for 24 h. The phosphorylation and total protein levels of IRS1 and Akt were examined by Western blotting in the indicated groups (n = 3 per group). Representative images from one sample out of 3 for each group are shown. All data are presented as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001. SelS-KD/KD-CON, SelS knockdown and the corresponding control; SelS-OE/OE-CON, SelS overexpression and the corresponding control; IRS1, insulin receptor substrate 1; Akt/PKB, protein kinase B; PKCɛ, protein kinase Cɛ.

    Article Snippet: To investigate the effects of SelS on hepatosteatosis and insulin signaling in vitro, the primary hepatocytes were treated with 0.5 mM PA for 24 h after infected with corresponding adenoviruses for 24 h. To identify the role of protein kinase Cɛ (PKCɛ) in insulin signaling, the primary hepatocytes were preincubated with PKCɛ inhibitor (ε-V1-2, 1 μM, MedChemExpress, New Jersey, USA) or PKCɛ activator (DCP-LA, 100 nM, MedChemExpress) for 1 h after adenovirus infection, and then the hepatocytes were treated with 0.5 mM PA for 24 h. Changes in the phosphorylation levels of IRS1 and Akt in cells were measured.

    Techniques: Activation Assay, In Vitro, Phospho-proteomics, Western Blot, Membrane, Infection, Knockdown, Control, Over Expression